CN106721280A - One kind is used for the 110kg fattening period pig antibiotic-free mixed feedstuffs of the genealogy of law 60 and application - Google Patents
One kind is used for the 110kg fattening period pig antibiotic-free mixed feedstuffs of the genealogy of law 60 and application Download PDFInfo
- Publication number
- CN106721280A CN106721280A CN201611120844.5A CN201611120844A CN106721280A CN 106721280 A CN106721280 A CN 106721280A CN 201611120844 A CN201611120844 A CN 201611120844A CN 106721280 A CN106721280 A CN 106721280A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- feed
- genealogy
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 102000004190 Enzymes Human genes 0.000 claims abstract description 15
- 108090000790 Enzymes Proteins 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 11
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 11
- 239000011782 vitamin Substances 0.000 claims abstract description 11
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 10
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 10
- 238000009472 formulation Methods 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 9
- 240000008042 Zea mays Species 0.000 claims abstract description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 8
- 150000001413 amino acids Chemical class 0.000 claims abstract description 8
- 235000005822 corn Nutrition 0.000 claims abstract description 8
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 8
- 239000004310 lactic acid Substances 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 7
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims abstract description 6
- 244000068988 Glycine max Species 0.000 claims abstract description 5
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 5
- 235000013312 flour Nutrition 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 239000004575 stone Substances 0.000 claims abstract description 5
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 4
- 241000282887 Suidae Species 0.000 claims abstract description 4
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims abstract description 4
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 claims abstract description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 4
- 235000019691 monocalcium phosphate Nutrition 0.000 claims abstract description 4
- 239000004615 ingredient Substances 0.000 claims abstract description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 229940024606 amino acid Drugs 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 5
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 235000006109 methionine Nutrition 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004382 Amylase Substances 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- 239000004470 DL Methionine Substances 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 229930003448 Vitamin K Natural products 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 229940085298 biotin 10 mg Drugs 0.000 claims description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011572 manganese Substances 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 235000019168 vitamin K Nutrition 0.000 claims description 3
- 239000011712 vitamin K Substances 0.000 claims description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940065528 vitamin b6 250 mg Drugs 0.000 claims description 3
- 229940046010 vitamin k Drugs 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 230000003115 biocidal effect Effects 0.000 description 19
- 241000282898 Sus scrofa Species 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 13
- 238000012360 testing method Methods 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241001071864 Lethrinus laticaudis Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000035611 feeding Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- -1 acid Natural products 0.000 description 1
- 238000000184 acid digestion Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 101150039403 ams gene Proteins 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 229960005364 bacitracin zinc Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- RKLXDNHNLPUQRB-TVJUEJKUSA-N chembl564271 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]2C(C)SC[C@H](N[C@@H](CC(N)=O)C(=O)NC(=O)[C@@H](NC2=O)CSC1C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NC(=C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NC(=O)C(=C\C)/NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@H]3N[C@@H](CC(C)C)C(=O)NC(=O)C(=C)NC(=O)CC[C@H](NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=4C5=CC=CC=C5NC=4)CSC3)C(O)=O)C(C)SC2)C(C)C)C(C)SC1)C1=CC=CC=C1 RKLXDNHNLPUQRB-TVJUEJKUSA-N 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940041153 polymyxins Drugs 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 108010082567 subtilin Proteins 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- UCRLQOPRDMGYOA-DFTDUNEMSA-L zinc;(4r)-4-[[(2s)-2-[[(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2s,3s)-1-[[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carbox Chemical compound [Zn+2].C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@H](CC([O-])=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 UCRLQOPRDMGYOA-DFTDUNEMSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Fodder In General (AREA)
Abstract
The present invention relates to pig's feed, it is specifically a kind of to be used for the 110kg growing and fattening pigs antibiotic-free mixed feedstuffs of the genealogy of law 60, the feed ingredient is in terms of parts by weight, including 5 10 parts of 400 450 parts of corn, 200 250 parts of dregs of beans, 300 350 parts of barley, 5 10 parts of soya-bean oil, 15 20 parts of stone flour, 15 20 parts of calcium dihydrogen phosphate, vitamin and microelement pre-mix material, 15 parts of salt, 0.1 0.5 parts of bacillus subtilis, 0.1 0.5 parts of complex enzyme formulation, 15 parts of lactic acid, 3 parts of amino acid/11.Application effect of products of the present invention is good.
Description
Technical field
The present invention relates to pig's feed, specifically one kind is matched somebody with somebody for genealogy of law 60-110kg fattening period pig antibiotic-frees
Close feed and application.
Background technology
Since the 1950's, antibiotic creates huge economic benefit to aquaculture.Antibiotic is made always
For feed growth-promoting additive is widely used, the extensive use yet with antibiotic in animal and fowl fodder is especially exceeded to be made
With, cause various pathogenic microorganisms to develop immunity to drugs, and animal suprainfection, have a strong impact on livestock birds health situation；Also by
Suspection can cause animal products drug residue, not only influence the quality and its security of animal products, also result in mankind's body
Interior pathogenic microorganism produces drug resistance to antibiotic, and then directly threatens human health.
China is antibiotic usage big country, is also antibiotics production big country.(U.S. is only for 138 grams or so of annual consumption per capita
13 grams).China's antibiotic half is used for clinic, and half is used for livestock breeding industry.Expert's reckoning, about the 21 of the annual production of China
There are 9.7 ten thousand tons in ten thousand tons of antibiotic raw materials for livestock breeding industry, account for the 46.1% of gross annual output amount..The whole industry is pursuing maximum
Disappointed under the driving of economic interests to turn round and look at social responsibility and food security, arbitrarily addition or excess add antibiotic in feed, can
To say the abuse for not existing antibiotic all the time in butchering the listing whole production cycle from animal birth.The abuse of antibiotic
Cause serious public health problem.
In animal husbandry, Escherichia coli, staphylococcus, salmonella etc. pass by the bacterial disease of not serious or less generation,
One of Infectious Diseases of poultry are risen to, this have direct relation with long-term use antibiosis.From nineteen ninety to 2011
Successively have tens place scholar carries out drug to the swine Escherichia coli of China and fowl source Escherichia coli, as a result shows：Greatly
The drug resistance of enterobacteria is more and more stronger, and 95% antibiotic had been out sensitiveness, the resistance that bacterial strain is averagely carried in recent years
Up to 17 kinds of gene.The more serious area of antibiotic application, the drug resistance of bacterium is stronger, with serious pollution in these antibiotic
Sensitive medicaments are found in area becomes more and more difficult.Once outburst drug tolerant bacteria disease, will result in serious economic loss.
With the great attention of the food-safe problem in countries in the world, it is negative that abuse of antibiotics feed addictive is brought
Influence is increasingly subject to social concerns.Many countries release the use of some laws and regulations specification Antibiotic Additives, Europe successively
Alliance etc. even forbids adding antibiotic in animal and fowl fodder.
The content of the invention
The present invention does not use antibiotic, and bacteria agent, enzyme preparation of environmental protection etc. are especially added with mixed feed.
One kind is used for genealogy of law 60-110kg growing and fattening pigs antibiotic-free mixed feedstuffs, and the feed ingredient is wrapped in terms of parts by weight
Include corn 400-450 parts, dregs of beans 200-250 parts, barley 300-350 parts, soya-bean oil 5-10 parts, stone flour 15-20 parts, calcium dihydrogen phosphate
15-20 parts, vitamin and microelement pre-mix material 5-10 parts, salt 1-5 parts, bacillus subtilis 0.1-0.5 parts, complex enzyme formulation
0.1-0.5 parts, lactic acid 1-5 parts, -3 parts of amino acid/11.
Described vitamin and microelement pre-mix material is made up of following components：Contain vitamin A in per kg premixes
1250KIU, vitamine D3 1000KIU, vitamin E 3600mg, vitamin K 400mg, vitamin B1 240mg, vitamin B2
1360mg, vitamin B6 250mg, vitamin B12 5.0mg, nicotinic acid 6000mg, pantothenic acid 3600mg, folic acid 60mg, biotin
10mg, iron 45g, copper 16g, zinc 20g, manganese 10g, iodine 1g, selenium 0.1g.
Number of viable >=20,300,000,000 CFU/g in the bacillus subtilis
The complex enzyme formulation consists of composition：Contain zytase 5000U, β-sweet dew in per g complex enzyme formulations
Dextranase 100000U, amylase 1000U, alpha-galactosidase 140U, protease 5000U.
The amino acid is made up of one or two or more kinds in following：1B, DL- METHIONINE, threonine, color ammonia
Acid, valine, phenylalanine, isoleucine, leucine.
Bacillus subtilis is the bacillus of aerobic gas.It is one kind of Bacillus, without pod membrane, peritrichous, energy
Motion, Grain stain is positive.Its function：1. during bacillus subtilis thalli growth produce subtilin, polymyxins,
Nystatin, gramicidins isoreactivity material, these active materials have bright to the conditioned pathogen of pathogenic bacteria or autogenous infection
Aobvious inhibitory action.2. bacillus subtilis consumes rapidly the free oxygen in enteron aisle, causes enteron aisle hypoxemia, promotes beneficial anaerobic bacteria
Growth, and the organic acids such as lactic acid are produced, enteron aisle pH value is reduced, other pathogenic bacteria growings are suppressed indirectly.3. stimulating animal is immunized
Growing for organ, activates T, bone-marrow-derived lymphocyte, improves immunoglobulin and antibody level, and enhancing cellular immunity and body fluid are exempted from
Epidemic disease function, improves herd immunity.4. bacillus subtilis thalline itself synthesizes AMS, protease, lipase, cellulose
The enzymes such as enzyme, together play a role in alimentary canal with the digestive enzymes in animal body.5. can synthetic vitamin B1, B2, B6, cigarette
Various B family vitamins such as acid, improve the activity of interferon and macrophage in animal body.
Complex enzyme formulation its component is：Alpha-galactosidase, 'beta '-mannase.
The ANFs such as galactoside present in alpha-galactosidase function 1, effectively degraded feed, reduce chyme and glue
Degree, reduces the generation of diarrhoea.2nd, plant cell wall construction is destroyed, promotes intracellular nutritional substance release, improve nutrition in feed
The utilization ratio of material.3rd, the suppression that ANFs is secreted to para-insulin like growth factor IGF-I is eliminated, promotes protein
Synthesis, improve lean meat percentage.4th, the Flatulent factors in degraded beans for feed, substantially reduce the young animal abdomen of bean material initiation
Rush down phenomenon.5th, strengthen the immunologic function and resistance against diseases of animal, reduce the consumption of antibiotic in feed.
'beta '-mannase function：1st, interference of the mannosan to glucose absorption in feed is eliminated, dregs of beans is greatly improved
Energy digestibility, can give corn bean pulp type daily ration improve 100-150kcal/kg metabolizable energy.2nd, mannosan is decomposed and produced
Manna oligosacchride, can by animal intestinal tract beneficial bacterium absorb, improve flora composition, reduce Escherichia coli, the sense of salmonella
Dye.3rd, enteron aisle viscosity is reduced, promotes energy, albumen, the digestion and absorption of cellulose.
Lactic acid its function is：1st, as growth promoter.Lactic acid can reduce the pH value in stomach, play activation digestive ferment,
Improve the effect of amino acid digestion ability, and it is beneficial to the growth of gut epithelium.Several week feedings of the piggy after ablactation
Feed containing acidulant, its body weight during weaning can increase by 15%.2nd, the growth of microorganism is suppressed.Nursing period it is small
Pig can be caught by Escherichia coli and salmonellal disease, disease in adding lactic acid to prevent piggy lower gastrointestinal tract in feed
Opportunistic pathogen grows.3rd, can as the preservative of feed and promote feed, cereal and meat packing product byproduct microorganism it is steady
Determine agent.
Application effect of products of the present invention is good, and the daily gain of pig is obvious.
Specific embodiment
The present invention is described in further detail with reference to reality.
Embodiment 1 is a kind of to be used for genealogy of law 60-110kg fattening period pig antibiotic-free mixed feedstuffs, the parts by weight of its composition
For：400 parts of corn, 230 parts of dregs of beans, 317 parts of barley, 7.6 parts of soya-bean oil, 15 parts of stone flour, 16 parts of calcium dihydrogen phosphate, vitamin and micro-
5 parts of trace mineral feed, 4 parts of salt, 0.2 part of bacillus subtilis, 0.2 part of complex enzyme formulation, 3 parts of lactic acid, amino acid/11 part.
Wherein vitamin and microelement pre-mix material are constituted：1250KIU containing vitamin A, vitamine D3 in per kg premixes
1000KIU, vitamin E 3600mg, vitamin K 400mg, vitamin B1 240mg, vitamin B2 1360mg, vitamin B6
250mg, vitamin B12 5.0mg, nicotinic acid 6000mg, pantothenic acid 3600mg, folic acid 60mg, biotin 10mg, iron 45g, copper 16g,
Zinc 20g, manganese 10g, iodine 1g, selenium 0.1g.
Wherein complex enzyme formulation is constituted：Contain zytase 5000U, 'beta '-mannase in per g complex enzyme formulations
100000U, amylase 1000U, alpha-galactosidase 140U, protease 5000U.
Number of viable >=20,300,000,000 CFU/g wherein in bacillus subtilis.
Wherein amino acid by 1B, DL- METHIONINE, threonine with 3:2:1 weight ratio is mixed.
Contrast test：
It is used for genealogy of law 60-110kg fattening period pig antibiotic-free mixed feedstuff using effects for the checking present invention is a kind of, at certain
Tested on genealogy of law pig pig farm.By the routine feeding genealogy of law fattening period pig 90 of 16 weeks, 3 groups are randomly divided into, every group 30, divided
Control group 1, control group 2 and test group are not named as；Control group 1 feeds (by weight, 600 parts of corn, wheat using conventional feed
Normal diet after 30 parts of bran, 100 parts of crushing of dregs of beans), control group 2 is fattened using the 60-110 containing antibiotic that certain feed factory is produced
Phase swine feed feeds (by weight, 625 parts of corn, 190 parts of dregs of beans, 50 parts of rice bran, 50 parts of corn germ cake, whitewashing jade
30 parts of skin of rice, 10 parts of soya-bean oil, 21 parts of stone flour, 5 parts of calcium monohydrogen phosphate, 4 parts of salt, 10 parts of premix, 0.8 part of Choline Chloride, lysine 4
Part, 0.6 part of methionine, montmorillonite 2 part, 4.9 parts of zeolite powder, 0.5 part of Bacitracin Zinc) test group use present example 1, in examination
Before testing and experimental period 2,30 day morning respectively empty stomach pig carry out it is single weigh, calculate weightening, feed intake and feedstuff-meat ratio.Experiment knot
Fruit is shown in Table 1
Influence of the DIFFERENT FEED of table 1 to 60-110kg fattening period pig production performances
| Project | Control group 1 | Control group 2 | Test group |
| Test pig (n) | 30 | 30 | 30 |
| Average starting weight (kg) | 60.21 | 60.23 | 60.42 |
| Average end weight (kg) | 81.15 | 85.04 | 89.22 |
| Average weight gain (kg) | 20.94 | 24.81 | 28.80 |
| Experimental period (d) | 30 | 30 | 30 |
| Average daily gain (g/d) | 698 | 827 | 960 |
| Average daily gain (g) | 2243 | 2408 | 2450 |
| Feedstuff-meat ratio | 3.21 | 2.91 | 2.55 |
Table 1 shows that the starting weight of pig is not significantly different between each group；The pig average daily gain of test group is compared with control group 1, control
Group 2 is respectively increased 37%, 16%, and average daily gain increases 262g, 133g respectively, and feedstuff-meat ratio reduces by 0.66,0.36 respectively.
Daily gain using test pig of the invention is obvious, and daily ingestion amount is improved, feedstuff-meat ratio reduction.
Claims (6)
1. it is a kind of to be used for genealogy of law 60-110kg growing and fattening pigs antibiotic-free mixed feedstuffs, the feed ingredient in terms of parts by weight, including
Corn 400-450 parts, dregs of beans 200-250 parts, barley 300-350 parts, soya-bean oil 5-10 parts, stone flour 15-20 parts, calcium dihydrogen phosphate
15-20 parts, vitamin and microelement pre-mix material 5-10 parts, salt 1-5 parts, bacillus subtilis 0.1-0.5 parts, complex enzyme formulation
0.1-0.5 parts, lactic acid 1-5 parts, -3 parts of amino acid/11.
2. according to feed described in claim 1, it is characterised in that：Described vitamin and microelement pre-mix material are by following components
Constitute：1250KIU containing vitamin A, vitamine D3 1000KIU, vitamin E 3600mg, vitamin K in per kg premixes
400mg, vitamin B1 240mg, vitamin B2 1360mg, vitamin B6 250mg, vitamin B12 5.0mg, nicotinic acid
6000mg, pantothenic acid 3600mg, folic acid 60mg, biotin 10mg, iron 45g, copper 16g, zinc 20g, manganese 10g, iodine 1g, selenium 0.1g.
3. according to feed described in claim 1, it is characterised in that：Number of viable >=20,300,000,000 CFU/ in the bacillus subtilis
g。
4. according to feed described in claim 1, it is characterised in that：The complex enzyme formulation consists of composition：Per g complex enzymes
Contain zytase 5000U, 'beta '-mannase 100000U, amylase 1000U, alpha-galactosidase 140U, albumen in preparation
Enzyme 5000U.
5. according to feed described in claim 1, it is characterised in that：The amino acid is by one or two or more kinds structure in following
Into：1B, DL- METHIONINE, threonine, tryptophan, valine, phenylalanine, isoleucine, leucine.
6. a kind of application of the prescription requirement any feeds of 1-5, it is characterised in that：The feed is used for genealogy of law 60-
The feeding of 110kg fattening period pigs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611120844.5A CN106721280A (en) | 2016-12-08 | 2016-12-08 | One kind is used for the 110kg fattening period pig antibiotic-free mixed feedstuffs of the genealogy of law 60 and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611120844.5A CN106721280A (en) | 2016-12-08 | 2016-12-08 | One kind is used for the 110kg fattening period pig antibiotic-free mixed feedstuffs of the genealogy of law 60 and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106721280A true CN106721280A (en) | 2017-05-31 |
Family
ID=58881351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611120844.5A Pending CN106721280A (en) | 2016-12-08 | 2016-12-08 | One kind is used for the 110kg fattening period pig antibiotic-free mixed feedstuffs of the genealogy of law 60 and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106721280A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108935321A (en) * | 2018-08-02 | 2018-12-07 | 四川科为民生物技术有限公司 | One kind being rich in CLA nutrition swine rearing method |
| CN111466492A (en) * | 2020-06-05 | 2020-07-31 | 重庆蓝宏生猪养殖有限公司 | Feed premix for fattening pigs and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105053591A (en) * | 2015-07-14 | 2015-11-18 | 山西碧云天饲料有限公司 | Chocolate-added lactating sow compound feed and preparation method thereof |
| CN105248897A (en) * | 2015-09-11 | 2016-01-20 | 四川特驱投资集团有限公司 | Pig forage improving meat quality |
| CN106173254A (en) * | 2016-08-04 | 2016-12-07 | 湖南九鼎科技（集团）有限公司 | A kind of nonreactive child care pig's feed and preparation method thereof |
-
2016
- 2016-12-08 CN CN201611120844.5A patent/CN106721280A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105053591A (en) * | 2015-07-14 | 2015-11-18 | 山西碧云天饲料有限公司 | Chocolate-added lactating sow compound feed and preparation method thereof |
| CN105248897A (en) * | 2015-09-11 | 2016-01-20 | 四川特驱投资集团有限公司 | Pig forage improving meat quality |
| CN106173254A (en) * | 2016-08-04 | 2016-12-07 | 湖南九鼎科技（集团）有限公司 | A kind of nonreactive child care pig's feed and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108935321A (en) * | 2018-08-02 | 2018-12-07 | 四川科为民生物技术有限公司 | One kind being rich in CLA nutrition swine rearing method |
| CN111466492A (en) * | 2020-06-05 | 2020-07-31 | 重庆蓝宏生猪养殖有限公司 | Feed premix for fattening pigs and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ogbuewu et al. | Yeast (Saccharomyces cerevisiae) and its effect on production indices of livestock and poultry—a review | |
| CN104431614B (en) | A kind of Nonreactive piggy creep feed and uses thereof | |
| CN101223934B (en) | Novel safe biologic feed and application thereof | |
| CN104970257A (en) | Antibiotic-free beef cattle growing and fattening premix and feed | |
| CN104381689A (en) | Antibiotic-free piglet creep feed | |
| CN102696927A (en) | Antibiotic-free conservation fodder for piglets | |
| CN106509432A (en) | Piglet intestinal health improving and weaning stress reducing creep feed and preparation method thereof | |
| CN104322882A (en) | Complete formula feed capable of improving production performances of sows | |
| CN104982734A (en) | Hare growth fattening premix without antibiotics and feed | |
| CN105124177A (en) | Antibiotics-free premixed material and antibiotics-free feed for growth and fattening of mutton sheep | |
| US20170173066A1 (en) | Method of feeding animals glucomannoprotein products | |
| CN101455283A (en) | Low-phosphorus high-efficiency concentrated feed for growing-finishing pigs | |
| Jasim et al. | Effect of chitosan and antibiotic adding to corn-soybean diet on the productive performance of broiler chickens | |
| CN110326721A (en) | A kind of green nonreactive fleshy duck fodder and preparation method thereof | |
| CN101181007A (en) | Feedstuff which prescription uses hypo-powder in recommendation | |
| CN107373132A (en) | Enzyme preparation live pig mixed feed | |
| CN106578515A (en) | Antibiotic-free compound feed for French sows at gestation period and application of antibiotic-free compound feed | |
| CN110367390A (en) | A kind of nonreactive piggy premixed feed of high-efficiency environment friendly | |
| CN106376753A (en) | Compound pig feed without antibiotics and application | |
| CN106721280A (en) | One kind is used for the 110kg fattening period pig antibiotic-free mixed feedstuffs of the genealogy of law 60 and application | |
| Lawlor et al. | Effect of fumaric acid, calcium formate and mineral levels in diets on the intake and growth performance of newly weaned pigs | |
| CN106578516A (en) | Antibiotic-free compound feed for French sows of 25-60kg at growth period and application | |
| CN104322908A (en) | 60-100kg Min growth and fattening pig special-purposed feed and preparation method thereof | |
| CN104397408A (en) | Antibiotic-free concentrated feed for laying chicks and preparation method of antibiotic-free concentrated feed | |
| Cromwell | Feed additives in swine diets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |